
@article{ref1,
title="Predictive modeling for suicide-related outcomes and risk factors among patients with pain conditions: a systematic review",
journal="Journal of clinical medicine",
year="2022",
author="Huang, Shu and Lewis, Motomori O. and Bao, Yuhua and Adekkanattu, Prakash and Adkins, Lauren E. and Banerjee, Samprit and Bian, Jiang and Gellad, Walid F. and Goodin, Amie J. and Luo, Yuan and Fairless, Jill A. and Walunas, Theresa L. and Wilson, Debbie L. and Wu, Yonghui and Yin, Pengfei and Oslin, David W. and Pathak, Jyotishman and Lo-Ciganic, Wei-Hsuan",
volume="11",
number="16",
pages="e4813-e4813",
abstract="Suicide is a leading cause of death in the US. Patients with pain conditions have higher suicidal risks. In a systematic review searching observational studies from multiple sources (e.g., MEDLINE) from 1 January 2000-12 September 2020, we evaluated existing suicide prediction models' (SPMs) performance and identified risk factors and their derived data sources among patients with pain conditions. The suicide-related outcomes included suicidal ideation, suicide attempts, suicide deaths, and suicide behaviors. Among the 87 studies included (with 8 SPM studies), 107 suicide risk factors (grouped into 27 categories) were identified. The most frequently occurring risk factor category was depression and their severity (33%). Approximately 20% of the risk factor categories would require identification from data sources beyond structured data (e.g., clinical notes). For 8 SPM studies (only 2 performing validation), the reported prediction metrics/performance varied: C-statistics (n = 3 studies) ranged 0.67-0.84, overall accuracy(n = 5): 0.78-0.96, sensitivity(n = 2): 0.65-0.91, and positive predictive values(n = 3): 0.01-0.43. Using the modified Quality in Prognosis Studies tool to assess the risk of biases, four SPM studies had moderate-to-high risk of biases. This systematic review identified a comprehensive list of risk factors that may improve predicting suicidal risks for patients with pain conditions. Future studies need to examine reasons for performance variations and SPM's clinical utility.<p /> <p>Language: en</p>",
language="en",
issn="2077-0383",
doi="10.3390/jcm11164813",
url="http://dx.doi.org/10.3390/jcm11164813"
}